{{Drugbox
| Watchedfields = changed
| verifiedrevid = 459493742
| IUPAC_name = 5,5-Diethyl-1-methylpyrimidine-2,4,6(1''H'',3''H'',5''H'')-trione
| image = Metharbital.svg
| width = 115
| image2 = Metharbital ball-and-stick.png
| width2 = 150

<!--Clinical data-->
| tradename =  
| Drugs.com =
| pregnancy_category =  
| legal_CA = Schedule IV
| legal_US = Schedule III
| routes_of_administration = [[Oral administration|By mouth]] ([[Tablet (pharmacy)|tablets]])

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =

<!--Identifiers-->
| IUPHAR_ligand = 7230
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 50-11-3
| ATC_prefix = N03
| ATC_suffix = AA30
| ATC_supplemental =  
| PubChem = 4099
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00463
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3957
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 02OS7K758T
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01382
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 450
| synonyms = Endiemal, metharbitone, methobarbitone<ref>[http://ctdbase.org/detail.go?type=chem&acc=C084822 The Comparative Toxicogenomics Database: Metharbital]</ref>

<!--Chemical data-->
| C=9 | H=14 | N=2 | O=3
| molecular_weight = 198.219 g/mol
| smiles = O=C1N(C(=O)NC(=O)C1(CC)CC)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C9H14N2O3/c1-4-9(5-2)6(12)10-8(14)11(3)7(9)13/h4-5H2,1-3H3,(H,10,12,14)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FWJKNZONDWOGMI-UHFFFAOYSA-N
}}

'''Metharbital''' was patented in 1905 by [[Hermann Emil Fischer|Emil Fischer]] working for [[Merck KGaA|Merck]].<ref>US Patent 782742</ref> It was marketed as '''Gemonil''' by [[Abbott Laboratories]]. It is a [[barbiturate]] [[anticonvulsant]], used in the treatment of [[epilepsy]].<ref>''The Treatment of Epilepsy 2nd Ed'' by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. {{ISBN|0-632-06046-8}}</ref><ref>''The Medical Treatment of Epilepsy'' by Stanley R Resor. Published by Marcel Dekker (1991). {{ISBN|0-8247-8549-5}}</ref> It has similar properties to [[phenobarbital]].

== History ==
* '''1952''' Gemonil was introduced by Abbott Laboratories. 
* '''1990''' Abbott stopped marketing.

==Synthesis==
Metharbital can be synthesized from 2,2-diethylmalonic acid and ''O''-methylisourea.<ref>A. Halpern, J.W. Jones, J. Am. Pharm. Assoc., 38, 352 (1949)</ref><ref>{{Cite journal | last1 = Snyder | first1 = J. A. 
| title = Preparation and Characterization by Alkaline Methanolysis of 5,5-Diethyl-4-(tetraacetyl-Î²-D-glucosyloxy)-2,6(1,5)-pyrimidinedione | last2 = Link | first2 = K. P. | journal = Journal of the American Chemical Society | volume = 75 | issue = 8 | pages = 1881 | year = 1953 | doi = 10.1021/ja01104a030}}</ref><ref>{{US patent|782742}}</ref>

==References==
{{reflist}}

{{Anticonvulsants}}
{{GABAAR PAMs}}

[[Category:Anticonvulsants]]
[[Category:Barbiturates]]
[[Category:GABAA receptor positive allosteric modulators]]

{{anticonvulsant-stub}}